{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T03:31:39Z","timestamp":1769052699726,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009015","name":"Abbott Japan Co. Ltd.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009015","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bristol-Myers K.K"},{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Astellas Pharma Inc."},{"DOI":"10.13039\/501100012351","name":"Mitsubishi Tanabe Pharma Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012351","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eisai Co. Ltd."},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010793","name":"Pfizer Japan Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010793","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Merck Sharp and Dohme Inc."},{"name":"Teijin Pharma Limited"},{"name":"Takeda Pharmaceutical Company Limited"},{"DOI":"10.13039\/501100005928","name":"Daiwa Securities Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008728","name":"Japan Research Foundation for Clinical Pharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008728","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Nakatomi Foundation"},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb Co.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008734","name":"Mitsui Sumitomo Insurance Welfare Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008734","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Hospital Organization"},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"DOI":"10.1186\/s41927-025-00605-9","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T16:46:30Z","timestamp":1765903590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lengthened telomere length in peripheral blood leukocytes in patients with rheumatoid arthritis complicated with airway disease"],"prefix":"10.1186","volume":"10","author":[{"given":"Takashi","family":"Higuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shomi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misuzu","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michita","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Saisho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Migita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouhei","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Tohma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"issue":"10055","key":"605_CR1","first-page":"2023","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid Arthritis Lancet. 2016;388(10055):2023\u201338.","journal-title":"Rheumatoid Arthritis Lancet"},{"issue":"1129939","key":"605_CR2","doi-asserted-by":"publisher","first-page":"1129939","DOI":"10.3389\/fmed.2023.1129939","volume":"10","author":"A Stainer","year":"2023","unstructured":"Stainer A, Tonutti A, De Santis M, et al. Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review. Front Med (Lausanne). 2023;10(1129939):1129939.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"605_CR3","doi-asserted-by":"publisher","first-page":"e33133","DOI":"10.1371\/journal.pone.0033133","volume":"7","author":"H Furukawa","year":"2012","unstructured":"Furukawa H, Oka S, Shimada K, et al. Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: A protective role for shared epitope. PLoS ONE. 2012;7(5):e33133.","journal-title":"PLoS ONE"},{"issue":"8","key":"605_CR4","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","volume":"49","author":"G Koduri","year":"2010","unstructured":"Koduri G, Norton S, Young A, et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology. 2010;49(8):1483\u20139.","journal-title":"Rheumatology"},{"issue":"6","key":"605_CR5","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1183\/09031936.00092309","volume":"35","author":"EJ Kim","year":"2010","unstructured":"Kim EJ, Elicker BM, Maldonado F, et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2010;35(6):1322\u20138.","journal-title":"Eur Respir J"},{"issue":"2","key":"605_CR6","first-page":"e22367","volume":"14","author":"AT Azam","year":"2022","unstructured":"Azam AT, Odeyinka O, Alhashimi R, et al. Rheumatoid arthritis and associated lung diseases: A comprehensive review. Cureus. 2022;14(2):e22367.","journal-title":"Cureus"},{"issue":"11","key":"605_CR7","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.rmed.2012.07.006","volume":"106","author":"S Mori","year":"2012","unstructured":"Mori S, Koga Y, Sugimoto M. Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis. Respir Med. 2012;106(11):1591\u20139.","journal-title":"Respir Med"},{"issue":"135","key":"605_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/09059180.00008014","volume":"24","author":"M Shaw","year":"2015","unstructured":"Shaw M, Collins BF, Ho LA, Raghu G. Rheumatoid arthritis-associated lung disease. Eur Respir Rev. 2015;24(135):1\u201316.","journal-title":"Eur Respir Rev"},{"issue":"5","key":"605_CR9","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1164\/ajrccm.157.5.9710018","volume":"157","author":"T Perez","year":"1998","unstructured":"Perez T, Remy-Jardin M, Cortet B. Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med. 1998;157(5):1658\u201365.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"605_CR10","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1183\/09031936.97.10051072","volume":"10","author":"A Vergnenegre","year":"1997","unstructured":"Vergnenegre A, Pugnere N, Antonini MT, et al. Airway obstruction and rheumatoid arthritis. Eur Respir J. 1997;10(5):1072\u20138.","journal-title":"Eur Respir J"},{"issue":"6","key":"605_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/rheumatology\/36.6.689","volume":"36","author":"DR Swinson","year":"1997","unstructured":"Swinson DR, Symmons D, Suresh U, Jones M, Booth J. Decreased survival in patients with co-existent rheumatoid arthritis and bronchiectasis. Br J Rheumatol. 1997;36(6):689\u201391.","journal-title":"Br J Rheumatol"},{"issue":"23","key":"605_CR12","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","volume":"379","author":"PA Juge","year":"2018","unstructured":"Juge PA, Lee JS, Ebstein E, et al. MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease. N Engl J Med. 2018;379(23):2209\u201319.","journal-title":"N Engl J Med"},{"key":"605_CR13","doi-asserted-by":"crossref","unstructured":"Higuchi T, Oka S, Shimada K, et al. Association of rare single nucleotide variant MUC5B rs35705950 with interstitial lung disease in Japanese rheumatoid arthritis. Rheumatology (Oxford). 2024;7(10).","DOI":"10.1093\/rheumatology\/keae422"},{"issue":"3","key":"605_CR14","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/rheumatology\/keab441","volume":"61","author":"E J\u00f6nsson","year":"2022","unstructured":"J\u00f6nsson E, Ljung L, Norrman E, et al. Pulmonary fibrosis in relation to genetic loci in an inception cohort of patients with early rheumatoid arthritis from Northern Sweden. Rheumatology (Oxford). 2022;61(3):943\u201352.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"605_CR15","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1136\/rmdopen-2022-002828","volume":"9","author":"T Higuchi","year":"2023","unstructured":"Higuchi T, Oka S, Furukawa H, et al. Association of a FAM13A variant with interstitial lung disease in Japanese rheumatoid arthritis. RMD Open. 2023;9(1):2022\u2013002828.","journal-title":"RMD Open"},{"issue":"3","key":"605_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/art.1780300302","volume":"30","author":"V Radoux","year":"1987","unstructured":"Radoux V, Menard HA, Begin R, Decary F, Koopman WJ. Airways disease in rheumatoid arthritis patients. One element of a general exocrine dysfunction. Arthritis Rheum. 1987;30(3):249\u201356.","journal-title":"Arthritis Rheum"},{"issue":"1\u20132","key":"605_CR17","first-page":"19","volume":"4","author":"MC Sweatman","year":"1986","unstructured":"Sweatman MC, Markwick JR, Charles PJ, et al. Histocompatibility antigens in adult obliterative bronchiolitis with or without rheumatoid arthritis. Dis Markers. 1986;4(1\u20132):19\u201326.","journal-title":"Dis Markers"},{"issue":"9","key":"605_CR18","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/rheumatology\/32.9.794","volume":"32","author":"MC Hillarby","year":"1993","unstructured":"Hillarby MC, McMahon MJ, Grennan DM, et al. HLA associations in subjects with rheumatoid arthritis and bronchiectasis but not with other pulmonary complications of rheumatoid disease. Br J Rheumatol. 1993;32(9):794\u20137.","journal-title":"Br J Rheumatol"},{"issue":"1","key":"605_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/rheumatology\/34.1.37","volume":"34","author":"WU Hassan","year":"1995","unstructured":"Hassan WU, Keaney NP, Holland CD, Kelly CA. Association of HLA-DR4, protease inhibitor phenotypes and keratoconjunctivitis Sicca with pulmonary abnormalities in rheumatoid arthritis. Br J Rheumatol. 1995;34(1):37\u201340.","journal-title":"Br J Rheumatol"},{"issue":"7","key":"605_CR20","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/rheumatology\/kew025","volume":"55","author":"S Oka","year":"2016","unstructured":"Oka S, Furukawa H, Shimada K, et al. Association of human leukocyte antigen alleles with chronic lung diseases in rheumatoid arthritis. Rheumatology (Oxford). 2016;55(7):1301\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"605_CR21","doi-asserted-by":"crossref","unstructured":"Higuchi T, Oka S, Furukawa H, et al. Association of a single nucleotide variant in TERT with airway disease in Japanese rheumatoid arthritis patients. Genes (Basel). 2023;14(11).","DOI":"10.3390\/genes14112084"},{"key":"605_CR22","doi-asserted-by":"crossref","unstructured":"Stock CJW, Renzoni EA. Telomeres in interstitial lung disease. J Clin Med 2021;10(7).","DOI":"10.3390\/jcm10071384"},{"issue":"6","key":"605_CR23","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/resp.12566","volume":"20","author":"J Dai","year":"2015","unstructured":"Dai J, Cai H, Li H, et al. Association between telomere length and survival in patients with idiopathic pulmonary fibrosis. Respirology. 2015;20(6):947\u201352.","journal-title":"Respirology"},{"issue":"5","key":"605_CR24","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/rheumatology\/kez524","volume":"59","author":"Z Zeng","year":"2020","unstructured":"Zeng Z, Zhang W, Qian Y, et al. Association of telomere length with risk of rheumatoid arthritis: a meta-analysis and Mendelian randomization. Rheumatology (Oxford). 2020;59(5):940\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"106943","key":"605_CR25","doi-asserted-by":"publisher","first-page":"106943","DOI":"10.1016\/j.rmed.2022.106943","volume":"201","author":"JG Natalini","year":"2022","unstructured":"Natalini JG, England BR, Baker JF, et al. Associations between shortened telomeres and rheumatoid arthritis-associated interstitial lung disease among U.S. Veterans. Respir Med. 2022;201(106943):106943.","journal-title":"Respir Med"},{"issue":"2","key":"605_CR26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1136\/thorax-2023-220022","volume":"79","author":"TJ Doyle","year":"2024","unstructured":"Doyle TJ, Juge PA, Peljto AL, et al. Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease. Thorax. 2024;79(2):182\u20135.","journal-title":"Thorax"},{"issue":"4","key":"605_CR27","doi-asserted-by":"publisher","first-page":"01641","DOI":"10.1183\/13993003.01641-2018","volume":"53","author":"CA Newton","year":"2019","unstructured":"Newton CA, Oldham JM, Ley B, et al. Telomere length and genetic variant associations with interstitial lung disease progression and survival. Eur Respir J. 2019;53(4):01641\u20132018.","journal-title":"Eur Respir J"},{"issue":"5","key":"605_CR28","doi-asserted-by":"publisher","first-page":"02314","DOI":"10.1183\/13993003.02314-2016","volume":"49","author":"PA Juge","year":"2017","unstructured":"Juge PA, Borie R, Kannengiesser C, et al. Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and Familial pulmonary fibrosis. Eur Respir J. 2017;49(5):02314\u20132016.","journal-title":"Eur Respir J"},{"issue":"9","key":"605_CR29","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American college of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569\u201381.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"605_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315\u201324.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"605_CR31","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1002\/cam4.2816","volume":"9","author":"J Ropio","year":"2020","unstructured":"Ropio J, Chebly A, Ferrer J, et al. Reliable blood cancer cells\u2019 telomere length evaluation by qPCR. Cancer Med. 2020;9(9):3153\u201362.","journal-title":"Cancer Med"},{"key":"605_CR32","doi-asserted-by":"crossref","unstructured":"P\u00e9ntek S, V\u00e1rnagy \u00c1, Farkas B, et al. Telomere length and telomerase activity of granulosa cells and follicular fluid in women undergoing in vitro fertilization. Antioxid (Basel). 2023;12(2).","DOI":"10.3390\/antiox12020419"},{"issue":"1","key":"605_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12891-017-1389-4","volume":"18","author":"S Oka","year":"2017","unstructured":"Oka S, Furukawa H, Shimada K, et al. Plasma MiRNA expression profiles in rheumatoid arthritis associated interstitial lung disease. BMC Musculoskelet Disord. 2017;18(1):21.","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"605_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/0197-2456(90)90005-M","volume":"11","author":"WD Dupont","year":"1990","unstructured":"Dupont WD, Plummer WD Jr. Power and sample size calculations. A review and computer program. Control Clin Trials. 1990;11(2):116\u201328.","journal-title":"Control Clin Trials"},{"issue":"8","key":"605_CR35","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/jama.1949.02900430001001","volume":"140","author":"O Steinbrocker","year":"1949","unstructured":"Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc. 1949;140(8):659\u201362.","journal-title":"J Am Med Assoc"},{"issue":"4","key":"605_CR36","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3904\/kjim.2024.148","volume":"40","author":"YB Joo","year":"2025","unstructured":"Joo YB, Bang SY, Hong SJ, et al. Association of peripheral leukocyte telomere length with patients with rheumatoid arthritis with a focus on interstitial lung disease. Korean J Intern Med. 2025;40(4):676\u201386.","journal-title":"Korean J Intern Med"},{"issue":"3","key":"605_CR37","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4046\/trd.2021.0015","volume":"84","author":"DH Moon","year":"2021","unstructured":"Moon DH, Kim J, Lim MN, Bak SH, Kim WJ. Correlation between telomere length and chronic obstructive pulmonary disease-Related phenotypes: results from the chronic obstructive pulmonary disease in dusty areas (CODA) cohort. Tuberc Respir Dis (Seoul). 2021;84(3):188\u201399.","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"768770","key":"605_CR38","first-page":"768770","volume":"8","author":"XR Han","year":"2021","unstructured":"Han XR, Cen LJ, Pan CX, et al. Decreased systemic and airway Sirtuin 1 expression in adults with bronchiectasis. Front Med (Lausanne). 2021;8(768770):768770.","journal-title":"Front Med (Lausanne)"},{"key":"605_CR39","doi-asserted-by":"crossref","unstructured":"da Silva CO, de Souza Nogueira J, do, Nascimento AP, et al. COPD patients exhibit distinct gene expression, accelerated cellular aging, and bias to M2 macrophages. Int J Mol Sci. 2023;24(12).","DOI":"10.3390\/ijms24129913"},{"issue":"6","key":"605_CR40","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/ng.2609","volume":"45","author":"TE Fingerlin","year":"2013","unstructured":"Fingerlin TE, Murphy E, Zhang W, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet. 2013;45(6):613\u201320.","journal-title":"Nat Genet"},{"issue":"11","key":"605_CR41","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S2213-2600(17)30387-9","volume":"5","author":"RJ Allen","year":"2017","unstructured":"Allen RJ, Porte J, Braybrooke R, et al. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study. Lancet Respir Med. 2017;5(11):869\u201380.","journal-title":"Lancet Respir Med"},{"issue":"10","key":"605_CR42","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/jmg.2008.057356","volume":"45","author":"T Mushiroda","year":"2008","unstructured":"Mushiroda T, Wattanapokayakit S, Takahashi A, et al. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J Med Genet. 2008;45(10):654\u20136.","journal-title":"J Med Genet"},{"issue":"4","key":"605_CR43","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/ng.2528","volume":"45","author":"V Codd","year":"2013","unstructured":"Codd V, Nelson CP, Albrecht E, et al. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet. 2013;45(4):422.","journal-title":"Nat Genet"},{"issue":"8","key":"605_CR44","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1164\/rccm.201510-2035LE","volume":"193","author":"J Birch","year":"2016","unstructured":"Birch J, Victorelli S, Rahmatika D, et al. Telomere dysfunction and Senescence-associated pathways in bronchiectasis. Am J Respir Crit Care Med. 2016;193(8):929\u201332.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"605_CR45","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1158\/1055-9965.EPI-06-0961","volume":"16","author":"M McGrath","year":"2007","unstructured":"McGrath M, Wong JY, Michaud D, Hunter DJ, De Vivo I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev. 2007;16(4):815\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"605_CR46","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/JPER.20-0269","volume":"92","author":"W Song","year":"2021","unstructured":"Song W, Yang J, Niu Z. Association of periodontitis with leukocyte telomere length in US adults: A cross-sectional analysis of NHANES 1999 to 2002. J Periodontol. 2021;92(6):833\u201343.","journal-title":"J Periodontol"},{"key":"605_CR47","doi-asserted-by":"publisher","first-page":"1654271","DOI":"10.3389\/fmed.2025.1654271","volume":"12","author":"S Oka","year":"2025","unstructured":"Oka S, Shimada K, Fujimori M, Hashimoto A, Komiya A, Saisho K, Yoshikawa N, Suzuki M, Matsui T, Fukui N, Migita K, Tohma S, Furukawa H. Anti-Porphyromonas gingivalis lipopolysaccharide antibody in rheumatoid arthritis patients with emphysema. Front Med (Lausanne). 2025;12:1654271.","journal-title":"Front Med (Lausanne)"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-025-00605-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-025-00605-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-025-00605-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T12:04:59Z","timestamp":1768997099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41927-025-00605-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["605"],"URL":"https:\/\/doi.org\/10.1186\/s41927-025-00605-9","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"27 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Review of the current study and its approval were performed by the Research Ethics Committees of Tokyo National Hospital (190010) and the institutes involved. Informed written consent was provided by all study participants. This study was performed according to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"STo received honoraria from Pfizer Japan Inc., Ono Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Astellas Pharma Inc., AbbVie GK., Chugai Pharmaceutical Co., Ltd., and Asahi Kasei Pharma Corporation. STo was supported by research grants from Pfizer Japan Inc., Teijin Pharma Ltd., Chugai Pharmaceutical Co., Ltd., Merck Sharp and Dohme Inc., Mitsubishi Tanabe Pharma Corporation, Astellas Pharma Inc., Takeda Pharmaceutical Company Ltd., Eisai Co., Ltd., and Abbott Japan Co., Ltd. HF received honoraria from Luminex Japan Corporation Ltd., Takeda Pharmaceutical Company, Pfizer Japan Inc., Daiichi Sankyo Co., Ltd., Ajinomoto Co., Inc., Dainippon Sumitomo Pharma Co., Ltd., and Ayumi Pharmaceutical Corporation. HF was supported by research grants from Nakatomi Foundation established by Hisamitsu Pharmaceutical Co., Inc., Bristol-Myers-Squibb Co., Japan Research Foundation for Clinical Pharmacology run by Daiichi Sankyo, Daiwa Securities Health Foundation established by Daiwa Securities Group Inc., Mitsui Sumitomo Insurance Welfare Foundation established by Mitsui Sumitomo Insurance Co., Ltd., and Takeda Science Foundation supported by Takeda Pharmaceutical Company.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}